AVEO PHARMACEUTICALS, INC.

Company

BIOGEN INC.

Filed

February 11, 2011

Accession Number

0000950123-11-012870

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →